MedTrace Logo

Metabolomics and Microbiomics in Cardiovascular Diseases

NCT04146701 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2021-02-16

No results posted yet for this study

Summary

"MEtabolomics and MicrObiomics in caRdIovAscular diseases Mannheim (MEMORIAM) " is a single-center, prospective and observational study investigating to identify disease-specific metabolic, respectively microbiomic, patterns of patients with high-risk cardiovascular diseases. High-risk cardiovascular diseases comprise patients suffering from acute heart failure (AHF), ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), sepsis, septic shock, ischemic and non-ischemic cardiomyopathy.

Conditions

  • Acute Heart Failure
  • NSTEMI - Non-ST Segment Elevation MI
  • STEMI - ST Elevation Myocardial Infarction
  • Myocardial Infarction, Acute
  • Sepsis
  • Cardiomyopathies
  • Dilated Cardiomyopathy
  • Ischemic Cardiomyopathy

Interventions

OTHER

Blood draw

venous blood withdraw (ca. 40ml)

Sponsors & Collaborators

  • Universitätsmedizin Mannheim

    lead OTHER

Principal Investigators

  • Michael Behnes, PD Dr. · University Medical Center Mannheim

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04146701 on ClinicalTrials.gov